Pfizer touts tripled salesforce productivity from AI rollout

AI healthcare is framed as a grounded alternative to the debt-fueled infrastructure buildout that has drawn warnings about a tech debt spiral. Rather than chasing data-center scale, the companies profiled apply machine learning to clinical and commercial bottlenecks. Pfizer's disclosure that AI and analytics have tripled international salesforce productivity and shortened clinical reporting timelines offers a concrete data point on how incumbents are using the technology to manage costs. CeriBell illustrates a different path: a smaller medtech player embedding seizure-detection algorithms directly into bedside brain monitoring for emergency and intensive care. Together they suggest the returns from AI in healthcare may show up first in operational efficiency and faster clinical decisions rather than in headline-grabbing model launches.